SARS-CoV-2
Scientists identify synthetic mini-antibody to combat COVID-19
By screening hundreds of sybodies (synthetic mini-antibodies), scientists have identified one that might stop SARS-CoV-2 from infecting human cells.…
Open data sharing accelerates COVID-19 research
Open access data benefits millions of scientists around the world and is essential for a rapid response to the COVID-19…
Repurposing drugs for a pan-coronavirus treatment
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
Flexible and protected – new findings on SARS-CoV-2 protein shed light on virus’s ability to infect cells
Researchers studied the spike protein on the surface of the SARS-CoV-2 virus. With its spikes, the virus binds to human cells and infects them. The…
Funding to predict the risk of infectious disease outbreaks
European collaboration receives funding to explore risks and impact of future infectious disease…
What COVID-19 is teaching us
The virtual EMBL Conference ‘SARS-CoV-2: Towards a New Era in Infection Research’ explored the importance of fundamental research, collaboration,…
Editing the mouse genome to study SARS-CoV-2 infection
To study how SARS-CoV-2 infects cells, the Gene Editing and Embryology Facility (GEEF) at EMBL Rome will generate mice that express a human version…
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical…
Silencing the SARS-CoV-2 receptor with epigenetic modifications
EMBL scientists develop a new molecular tool to prevent SARS-CoV-2 infection in mice. This tool is able to cause targeted epigenetic modifications of…
Investigating the structure and mechanisms of coronavirus biomolecules
While global research on coronaviruses has shed light on the function of many SARS-CoV-2 proteins, the role of some crucial components remains…
Understanding how SARS-CoV-2 behaves in the gut
Scientists at EMBL and Heidelberg University Hospital are studying how the novel coronavirus behaves in the gut to try to better understand its…
Improving our response to emerging pandemics
The emergence of previously unknown pathogens, such as the novel coronavirus SARS-CoV-2, raises many questions. To explore these questions in an…
Last 6 months:
- January 2021 (7)
- December 2020 (18)
- November 2020 (12)
- October 2020 (21)
- September 2020 (21)
- August 2020 (18)
By year:
By topics:
- Alumni (98)
- Events (161)
- Lab Matters (373)
- Picture of the week (91)
- Science (687)
EMBLetc.
Read the latest Issues of our magazine - EMBLetc.
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive